Neostigmine
Back to searchMolecule Structure
Scientific Name
Neostigmine
Description of the Drug
Neostigmine is a cholinesterase inhibitor used in the symptomatic treatment of myasthenia gravis by improving muscle tone.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01400
http://www.drugbank.ca/drugs/DB01400
Brand Name(s)
Not Available
Company Owner(s)
Fresenius Kabi Usa Llc, Par Sterile Products Llc, Caplin Steriles Ltd, Gland Pharma Ltd, American Regent Inc, Amphastar Pharmaceuticals Inc, Dr Reddys Laboratories Ltd, Exela Pharma Sciences Llc, Meitheal Pharmaceuticals Inc, Amneal Eu Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Acetylcholinesterase | SINGLE PROTEIN | INHIBITOR | CHEMBL220 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL34419 | |||
PharmGKB | PA450611 | |||
Human Metabolome Database | HMDB0015472 | |||
DrugBank | DB01400 | |||
PubChem: Thomson Pharma | 15121488 | |||
PubChem | 4456 | |||
Mcule | MCULE-3501840981 | |||
NMRShiftDB | 20200212 | |||
LINCS | LSM-5360 | |||
Nikkaji | J4.797J | |||
BindingDB | 50022775 | |||
EPA CompTox Dashboard | DTXSID1023360 | |||
DrugCentral | 1897 | |||
Brenda | 30362 | 2571 | 47472 | |
ChemicalBook | CB11351001 | |||
Guide to Pharmacology | 8993 | |||
rxnorm | BLOXIVERZ | NEOSTIGMINE BROMIDE | NEOSTIGMINE METHYLSULFATE | NEOSTIGMINE |
KEGG Ligand | C07258 | |||
ChEBI | 7514 | |||
ZINC | ZINC000000001792 |